- Home
- ELDN vs MYPS Comparison
ELDN vs MYPS Comparison
Compare ELDN & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- MYPS
- Stock Information
- Founded
- ELDN 2004
- MYPS 2011
- Country
- ELDN United States
- MYPS United States
- Employees
- ELDN N/A
- MYPS N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- MYPS EDP Services
- Sector
- ELDN Health Care
- MYPS Technology
- Exchange
- ELDN Nasdaq
- MYPS Nasdaq
- Market Cap
- ELDN 232.4M
- MYPS 218.2M
- IPO Year
- ELDN N/A
- MYPS N/A
- Fundamental
- Price
- ELDN $3.39
- MYPS $1.30
- Analyst Decision
- ELDN Strong Buy
- MYPS Hold
- Analyst Count
- ELDN 1
- MYPS 6
- Target Price
- ELDN $16.00
- MYPS $2.75
- AVG Volume (30 Days)
- ELDN 261.8K
- MYPS 210.7K
- Earning Date
- ELDN 03-20-2025
- MYPS 03-10-2025
- Dividend Yield
- ELDN N/A
- MYPS N/A
- EPS Growth
- ELDN N/A
- MYPS N/A
- EPS
- ELDN N/A
- MYPS N/A
- Revenue
- ELDN N/A
- MYPS $289,429,000.00
- Revenue This Year
- ELDN N/A
- MYPS N/A
- Revenue Next Year
- ELDN N/A
- MYPS N/A
- P/E Ratio
- ELDN N/A
- MYPS N/A
- Revenue Growth
- ELDN N/A
- MYPS N/A
- 52 Week Low
- ELDN $1.52
- MYPS $1.14
- 52 Week High
- ELDN $5.54
- MYPS $3.04
- Technical
- Relative Strength Index (RSI)
- ELDN 32.13
- MYPS 40.96
- Support Level
- ELDN $3.22
- MYPS $1.27
- Resistance Level
- ELDN $3.44
- MYPS $1.48
- Average True Range (ATR)
- ELDN 0.18
- MYPS 0.09
- MACD
- ELDN -0.01
- MYPS 0.02
- Stochastic Oscillator
- ELDN 20.31
- MYPS 49.25
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About MYPS PLAYSTUDIOS Inc.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore, and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.